Literature DB >> 23671793

Mutant SOD1 microglia-generated nitroxidative stress promotes toxicity to human fetal neural stem cell-derived motor neurons through direct damage and noxious interactions with astrocytes.

Jason R Thonhoff1, Junling Gao, Tiffany J Dunn, Luis Ojeda, Ping Wu.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a devastating motor neuron disease. Human neural stem cells (hNSCs) may have the potential to replace lost motor neurons. The therapeutic efficacy of stem cell therapy depends greatly on the survival of grafted stem cell-derived motor neurons in the microenvironment of the spinal cord in ALS. After transplantation of hNSCs into the spinal cords of transgenic ALS rats, morphological analysis reveals that grafted hNSCs differentiate into motor neurons. However, hNSCs degenerate and show signs of nitroxidative damage at the disease end-stage. Using an in vitro coculture system, we systematically assess interactions between microglia and astroglia derived from both nontransgenic rats and transgenic rats expressing human mutant SOD1(G93A) before and after symptomatic disease onset, and determine the effects of such microglia-astroglia interactions on the survival of hNSC-derived motor neurons. We found that ALS microglia, specifically isolated after symptomatic disease onset, are directly toxic to hNSC-derived motor neurons. Furthermore, nontransgenic astrocytes not only lose their protective role in hNSC-derived motor neuron survival in vitro, but also exhibit toxic features when cocultured with mutant SOD1(G93A) microglia. Using inhibitors of inducible nitric oxide synthase and NADPH oxidase, we show that microglia-generated nitric oxide and superoxide partially contribute to motor neuron loss and astrocyte dysfunction in this coculture paradigm. In summary, reactive oxygen/nitrogen species released from overactivated microglia in ALS directly eliminate human neural stem cell-derived motor neurons and reduce the neuroprotective capacities of astrocytes.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; astroglia; microglia; motor neuron; oxidative stress; transplantation

Year:  2011        PMID: 23671793      PMCID: PMC3643388     

Source DB:  PubMed          Journal:  Am J Stem Cells        ISSN: 2160-4150


  46 in total

1.  Development of a culture system that supports adult microglial cell proliferation and maintenance in the resting state.

Authors:  Eugene D Ponomarev; Marina Novikova; Katarzyna Maresz; Leah P Shriver; Bonnie N Dittel
Journal:  J Immunol Methods       Date:  2005-04-26       Impact factor: 2.303

2.  Reactive astrogliosis of the spinal cord in amyotrophic lateral sclerosis.

Authors:  D Schiffer; S Cordera; P Cavalla; A Migheli
Journal:  J Neurol Sci       Date:  1996-08       Impact factor: 3.181

3.  Transient recovery in a rat model of familial amyotrophic lateral sclerosis after transplantation of motor neurons derived from mouse embryonic stem cells.

Authors:  Rodrigo López-González; Philip Kunckles; Iván Velasco
Journal:  Cell Transplant       Date:  2009-08-05       Impact factor: 4.064

4.  Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons.

Authors:  Makiko Nagai; Diane B Re; Tetsuya Nagata; Alcmène Chalazonitis; Thomas M Jessell; Hynek Wichterle; Serge Przedborski
Journal:  Nat Neurosci       Date:  2007-04-15       Impact factor: 24.884

5.  Adult olfactory bulb neural precursor cell grafts provide temporary protection from motor neuron degeneration, improve motor function, and extend survival in amyotrophic lateral sclerosis mice.

Authors:  Lee J Martin; Zhiping Liu
Journal:  J Neuropathol Exp Neurol       Date:  2007-11       Impact factor: 3.685

6.  Increased cytotoxic potential of microglia from ALS-transgenic mice.

Authors:  Patrick Weydt; Eric C Yuen; Bruce R Ransom; Thomas Möller
Journal:  Glia       Date:  2004-11-01       Impact factor: 7.452

7.  Astrocytes enhance long-term survival of cholinergic neurons differentiated from human fetal neural stem cells.

Authors:  Paivi M Jordan; Lisa D Cain; Ping Wu
Journal:  J Neurosci Res       Date:  2008-01       Impact factor: 4.164

8.  Oxidative damage to protein in sporadic motor neuron disease spinal cord.

Authors:  P J Shaw; P G Ince; G Falkous; D Mantle
Journal:  Ann Neurol       Date:  1995-10       Impact factor: 10.422

9.  Mutant SOD1(G93A) microglia are more neurotoxic relative to wild-type microglia.

Authors:  Qin Xiao; Weihua Zhao; David R Beers; Albert A Yen; Wenjie Xie; Jenny S Henkel; Stanley H Appel
Journal:  J Neurochem       Date:  2007-06-07       Impact factor: 5.372

10.  Primary glia expressing the G93A-SOD1 mutation present a neuroinflammatory phenotype and provide a cellular system for studies of glial inflammation.

Authors:  Kenneth Hensley; Haitham Abdel-Moaty; Jerrod Hunter; Molina Mhatre; Shenyun Mou; Kim Nguyen; Tamara Potapova; Quentin N Pye; Min Qi; Heather Rice; Charles Stewart; Katharine Stroukoff; Melinda West
Journal:  J Neuroinflammation       Date:  2006-01-25       Impact factor: 8.322

View more
  3 in total

1.  Exosomes-carried microRNA-26b-5p regulates microglia M1 polarization after cerebral ischemia/reperfusion.

Authors:  Guangying Li; Longhai Xiao; Hao Qin; Qiang Zhuang; Weiwei Zhang; Long Liu; Chao Di; Yabo Zhang
Journal:  Cell Cycle       Date:  2020-03-25       Impact factor: 4.534

2.  Phenotypic transition of microglia into astrocyte-like cells associated with disease onset in a model of inherited ALS.

Authors:  Emiliano Trias; Pablo Díaz-Amarilla; Silvia Olivera-Bravo; Eugenia Isasi; Derek A Drechsel; Nathan Lopez; C Samuel Bradford; Kyle E Ireton; Joseph S Beckman; Luis Barbeito
Journal:  Front Cell Neurosci       Date:  2013-12-24       Impact factor: 5.505

3.  Emergence of Microglia Bearing Senescence Markers During Paralysis Progression in a Rat Model of Inherited ALS.

Authors:  Emiliano Trias; Pamela R Beilby; Mariángeles Kovacs; Sofía Ibarburu; Valentina Varela; Romina Barreto-Núñez; Samuel C Bradford; Joseph S Beckman; Luis Barbeito
Journal:  Front Aging Neurosci       Date:  2019-02-28       Impact factor: 5.702

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.